000 | 01956 a2200529 4500 | ||
---|---|---|---|
005 | 20250513061014.0 | ||
264 | 0 | _c19941020 | |
008 | 199410s 0 0 eng d | ||
022 | _a0091-3057 | ||
024 | 7 |
_a10.1016/0091-3057(94)90534-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWomer, D E | |
245 | 0 | 0 |
_aCharacterization of dopamine transporter and locomotor effects of cocaine, GBR 12909, epidepride, and SCH 23390 in C57BL and DBA mice. _h[electronic resource] |
260 |
_bPharmacology, biochemistry, and behavior _cJun 1994 |
||
300 |
_a327-35 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBenzamides _xpharmacology |
650 | 0 | 4 |
_aBenzazepines _xpharmacology |
650 | 0 | 4 |
_aBinding, Competitive _xdrug effects |
650 | 0 | 4 |
_aBrain _xmetabolism |
650 | 0 | 4 |
_aCarrier Proteins _xmetabolism |
650 | 0 | 4 |
_aCaudate Nucleus _xdrug effects |
650 | 0 | 4 |
_aCocaine _xantagonists & inhibitors |
650 | 0 | 4 |
_aDopamine _xmetabolism |
650 | 0 | 4 | _aDopamine Antagonists |
650 | 0 | 4 | _aDopamine Plasma Membrane Transport Proteins |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMembrane Glycoproteins |
650 | 0 | 4 | _aMembrane Transport Proteins |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Inbred DBA |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
650 | 0 | 4 | _aNerve Tissue Proteins |
650 | 0 | 4 |
_aNeurotransmitter Uptake Inhibitors _xpharmacokinetics |
650 | 0 | 4 |
_aNucleus Accumbens _xdrug effects |
650 | 0 | 4 |
_aPiperazines _xpharmacokinetics |
650 | 0 | 4 |
_aPyrrolidines _xpharmacology |
650 | 0 | 4 | _aSpecies Specificity |
700 | 1 | _aJones, B C | |
700 | 1 | _aErwin, V G | |
773 | 0 |
_tPharmacology, biochemistry, and behavior _gvol. 48 _gno. 2 _gp. 327-35 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0091-3057(94)90534-7 _zAvailable from publisher's website |
999 |
_c8090121 _d8090121 |